ArticleFrontiers in oncology2026
Case Report: Recurrent metastatic thymoma-associated multiple paraneoplastic syndromes: myasthenia gravis, dysgeusia, and acute intestinal pseudo-obstruction.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Paraneoplastic syndromes (PNS) are frequently associated with thymoma. The unusual clustering of myasthenia gravis, dysgeusia, and AIPO during thymoma recurrence has been sparsely reported in the literature. Case presentation: We report the case of a man who developed pleural metastasis three years after thymoma resection and shortly thereafter experienced dysgeusia, ocular MG (diplopia and ophthalmoplegia), and AIPO. This triad has received limited documentation. Serum testing was positive for acetylcholine receptor antibody (AChR-Ab), anti-MURC antibody, and anti-recoverin antibody. After combined CAP chemotherapy and symptomatic pyridostigmine therapy, the pleural lesions regressed, and the ocular, taste, and gastrointestinal symptoms also resolved. Conclusion: This case illustrates that multisystem PNS can arise years after thymectomy and may cluster, emphasizing the need for early recognition and multidisciplinary, comprehensive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.